Universe Pharmaceuticals INC
UPC
Analytical Summary
Universe Pharmaceuticals INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.
Bullish Indicators
- Debt to EquityDebt to Equity is in the top quartile (lower is better)
Bearish Risks
- Operating Margin (%)Operating Margin (%) is in the bottom quartile
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q4 FY2025 Sep 30, 2025 20-F ↗ | Q4 FY2024 Sep 30, 2024 20-F ↗ | Q4 FY2023 Sep 30, 2023 20-F ↗ | Q4 FY2022 Sep 30, 2022 20-F ↗ | Q4 FY2021 Sep 30, 2021 20-F ↗ | Q4 FY2020 Sep 30, 2020 20-F ↗ | Q4 FY2019 Sep 30, 2019 20-F ↗ | Q4 FY2018 Sep 30, 2018 20-F ↗ |
|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) |
0.13x
Excellent
↓
Excellent
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-79%)
|
0.13x
Excellent
↑
Excellent
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-79%)
|
0.20x
Excellent
↑
Excellent
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-67%)
|
0.08x
Excellent
↓
Excellent
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-86%)
|
0.07x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-88%)
|
0.13x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-79%)
|
— | — |
| Net Debt (USD) | $7.15B | $5.86B | $5.48M | $3.94M | $-3.74M | $-7.41M | $-3.18M | $-6.19M |
| Metric | Q4 FY2025 Sep 30, 2025 20-F ↗ | Q4 FY2024 Sep 30, 2024 20-F ↗ | Q4 FY2023 Sep 30, 2023 20-F ↗ | Q4 FY2022 Sep 30, 2022 20-F ↗ | Q4 FY2021 Sep 30, 2021 20-F ↗ | Q4 FY2020 Sep 30, 2020 20-F ↗ | Q4 FY2019 Sep 30, 2019 20-F ↗ | Q4 FY2018 Sep 30, 2018 20-F ↗ |
|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $40.43B | $31.32B | $11.52M | $28.41M | $39.27M | $15.28M | — | — |
| Total Equity (USD) | $56.13B | $45.50B | $27.97M | $46.44M | $58.93M | $20.80M | $12.38M | $9.68M |
Secondary lens
Benchmark Lens
Compare UPC against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare UPC against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for UPC
Debt to Equity is in the top quartile (lower is better)
Operating Margin (%) is in the bottom quartile
Profit Margin (%) is in the bottom quartile
Percentile Rankings
How UPC compares to all companies
Peer Comparison
UPC vs similar peers
Compare UPC with peers
Stack UPC against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 4 days ago 8 years · 8 quarters